Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

1,325 questions in 34 reviews · Oral medicine and oral cancer

current versions
No studies 164 · 12.4%Ungraded 841 · 63.5%Very low 209 · 15.8%Low 72 · 5.4%Moderate 38 · 2.9%High 1 · 0.1%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Antifungal drugs partially absorbed from GI tract (miconazole, clotrimazole) vs Placebo or no treatment
Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 0.16 [0.06, 0.46]4 studies · 292 participantsUngraded
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs Placebo or no treatment
Amount of analgesia · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
No trial reported this planned secondary outcome for any comparison in this reviewNRNo studies
Antifungal drugs absorbed from GI tract vs Antifungal drugs not absorbed from GI tract
Systemic fungal infection · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 0.59 [0.33, 1.06]8 studies · 2103 participantsUngraded
Itraconazole vs Fluconazole
Death associated with fungal infection · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 0.14 [0.01, 2.73]1 study · 202 participantsUngraded
Itraconazole vs Fluconazole
Good compliance · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 0.95 [0.85, 1.05]1 study · 202 participantsUngraded
Antifungal drugs partially absorbed from GI tract (miconazole, clotrimazole) vs Placebo or no treatment
Empirical antifungal treatment · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 3.38 [0.15, 77.12]1 study · 32 participantsUngraded
Antifungal drugs absorbed from GI tract vs Antifungal drugs not absorbed from GI tract
Death associated with fungal infection · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 1.25 [0.38, 4.13]3 studies · 981 participantsUngraded
Nystatin vs Chlorhexidine plus nystatin
Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 1.82 [0.73, 4.54]1 study · 50 participantsUngraded
Antifungal drugs not absorbed from GI tract vs Placebo or no treatment
Death associated with fungal infection · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 0.16 [0.01, 2.95]1 study · 51 participantsUngraded
Chlorhexidine vs Nystatin
Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 0.89 [0.36, 2.21]1 study · 34 participantsUngraded
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs Placebo or no treatment
Relief of pain · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
No trial reported this planned secondary outcome for any comparison in this reviewNRNo studies
Antifungal drugs absorbed from GI tract vs Antifungal drugs not absorbed from GI tract
Good compliance · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 1.05 [1.03, 1.08]1 study · 820 participantsUngraded
Nystatin vs Placebo or no treatment
Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 0.92 [0.78, 1.08]3 studies · 153 participantsUngraded
Nystatin vs Natamycin
Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 1.07 [0.83, 1.37]1 study · 28 participantsUngraded
Antifungal drugs absorbed from GI tract vs Antifungal drugs not absorbed from GI tract
Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 0.4 [0.21, 0.76]8 studies · 2103 participantsUngraded
Antifungal drugs not absorbed from GI tract vs Placebo or no treatment
Systemic fungal infection · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 0.1 [0.01, 1.75]2 studies · 71 participantsUngraded
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs Placebo or no treatment
Toxicity (adverse events probably due to drug) · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 1.18 [0.84, 1.67]3 studies · 871 participantsUngraded
Ketoconazole vs Itraconazole
Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
1 study (Caselli 1990); no evidence of a difference; not estimable/not pooled1 studyUngraded
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs Placebo or no treatment
Oral candidiasis (present) · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 0.47 [0.29, 0.78]7 studies · 1153 participantsUngraded
Antifungal drugs absorbed from GI tract vs Antifungal drugs not absorbed from GI tract
Toxicity (adverse events probably due to drug) · Patients with cancer receiving chemotherapy or radiotherapy or both
Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane
RR 0.88 [0.33, 2.3]6 studies · 2018 participantsUngraded
Tongue scraping (mechanical tongue cleaning) vs Placebo or no intervention (nothing)
Outcome NR · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis · Minimum 4 weeks (planned)
Tongue scraping for treating halitosis (2006) · Cochrane
No eligible randomized controlled trials comparing tongue scraping with placebo or no intervention were identified.0 studiesNo studies
Tongue scraper or tongue cleaner (One Drop Only tongue cleaner; Tongue-Putzer scraper; polystyrene scraper) vs Toothbrush (used to clean the tongue)
Volatile sulfur compound (VSC) levels measured by portable sulfide monitor · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis · Immediately to 35 min post-intervention (Seemann 2001); 1 week (Pedrazzi 2004)
Tongue scraping for treating halitosis (2006) · Cochrane
No summary of findings table or GRADE assessment (pre-GRADE review); narrative synthesis, data not pooled. Seemann 2001: peak VSC reduction 42% with the tongue cleaner, 40% with the tongue scraper and 33% with the…2 studies · 40 participantsUngraded
Tongue scraper or tongue cleaner (One Drop Only tongue cleaner; Tongue-Putzer scraper; polystyrene scraper) vs Toothbrush (used to clean the tongue)
Adverse effects (tongue trauma, nausea) and acceptability · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis · 1 week (Pedrazzi 2004)
Tongue scraping for treating halitosis (2006) · Cochrane
Pedrazzi 2004: six of ten (60%) participants complained of nausea and one participant of tongue trauma, only with the toothbrush; all participants were receptive to the tongue scraper. Seemann 2001: no adverse effects…2 studiesUngraded
Tongue scraper or tongue cleaner (One Drop Only tongue cleaner; Tongue-Putzer scraper; polystyrene scraper) vs Toothbrush (used to clean the tongue)
Self-expressed (perceived) or organoleptic (human nose) assessment of halitosis · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis · Minimum 4 weeks (planned)
Tongue scraping for treating halitosis (2006) · Cochrane
Neither of the two included trials provided any self expressed (perceived) or organoleptic (human nose) assessments of halitosis (the review's primary outcomes); no data.0 studiesNo studies
Tongue scraping (mechanical tongue cleaning) vs Mouthwash or other chemical intervention
Outcome NR · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis · Minimum 4 weeks (planned)
Tongue scraping for treating halitosis (2006) · Cochrane
No randomized controlled trials comparing mechanical tongue cleaning with mouthwashes were identified; the review notes "the somewhat unexpected lack of randomized controlled trials comparing the effectiveness of…0 studiesNo studies